Valeant planning to appoint new leader as CEO remains hospitalized

Valeant Pharmaceuticals International Inc. is planning to appoint a new chief executive while its CEO, Michael Pearson, remains under hospital care, said people familiar with the matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.